Exact Mass: 644.2482

Exact Mass Matches: 644.2482

Found 26 metabolites which its exact mass value is equals to given mass value 644.2482, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Reserpine HCl

YOHIMBAN-16-CARBOXYLIC ACID, 11,17-DIMETHOXY-18-((3,4,5-TRIMETHOXYBENZOYL)OXY)-, METHYL ESTER, MONOHYDROCHLORIDE, (3.BETA.,16.BETA.,17.ALPHA.,18.BETA.,20.ALPHA.)-

C33H41ClN2O9 (644.25)


Reserpine hydrochloride is an inhibitor of the vesicular monoamine transporter 2 (VMAT2). Reserpine hydrochloride is an inhibitor of the vesicular monoamine transporter 2 (VMAT2).

   

Lapaquistat acetate

2-[1-(2-{1-[3-(acetyloxy)-2,2-dimethylpropyl]-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl}acetyl)piperidin-4-yl]acetic acid

C33H41ClN2O9 (644.25)


   

kaempferide 3-glucoside-7-rhamnoside

1-(4-Hydroxy-3,5-dimethoxy-phenyl)-2-[4-[3-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2,6-dimethoxy-phenoxy]propane-1,3-diol

C33H40O13 (644.2469)


   
   

Cineracipadesin F

Cineracipadesin F

C33H40O13 (644.2469)


   
   
   

Me glycoside,4,6-O-benzylidene,3-benzyl,2,3,4-tri-Ac-Pyranose-2-O-alpha-L-Rhamnopyranosyl-D-galactose

Me glycoside,4,6-O-benzylidene,3-benzyl,2,3,4-tri-Ac-Pyranose-2-O-alpha-L-Rhamnopyranosyl-D-galactose

C33H40O13 (644.2469)


   

Me glycoside,4,6-O-benzylidene,2-benzyl,2,3,4-tri-Ac-beta-Pyranose-3-O-alpha-L-Rhamnopyranosyl-D-galactose

Me glycoside,4,6-O-benzylidene,2-benzyl,2,3,4-tri-Ac-beta-Pyranose-3-O-alpha-L-Rhamnopyranosyl-D-galactose

C33H40O13 (644.2469)


   
   

Lapaquistat Acetate

Lapaquistat Acetate

C33H41ClN2O9 (644.25)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent

   

1,1-[(phenylmethylene)bis[(2-methoxy-4,1-phenylene)azo]]bis(2-naphthol)

1,1-[(phenylmethylene)bis[(2-methoxy-4,1-phenylene)azo]]bis(2-naphthol)

C41H32N4O4 (644.2423)


   

Nazartinib mesylate trihydrate

Nazartinib mesylate trihydrate

C27H41ClN6O8S (644.2395)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents

   

kaempferide 3-glucoside-7-rhamnoside

1-(4-hydroxy-3,5-dimethoxyphenyl)-2-{4-[4-(4-hydroxy-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}propane-1,3-diol

C33H40O13 (644.2469)


   

(-)-(7R,7R,7S,8S,8S,8S)-4,4-dihydroxy-3,3,3,5,5,5-hexamethoxy-7,9:7,9-diepoxy-4,8-oxy-8,8-sesquineolignan-7,9-diol

(-)-(7R,7R,7S,8S,8S,8S)-4,4-dihydroxy-3,3,3,5,5,5-hexamethoxy-7,9:7,9-diepoxy-4,8-oxy-8,8-sesquineolignan-7,9-diol

C33H40O13 (644.2469)


A neolignan isolated from the stems of Sinocalamus affinis.

   

(-)-(7R,7R,7R,8S,8S,8S)-4,4-dihydroxy-3,3,3,5,5,5-hexamethoxy-7,9:7,9-diepoxy-4,8-oxy-8,8-sesquineolignan-7,9-diol

(-)-(7R,7R,7R,8S,8S,8S)-4,4-dihydroxy-3,3,3,5,5,5-hexamethoxy-7,9:7,9-diepoxy-4,8-oxy-8,8-sesquineolignan-7,9-diol

C33H40O13 (644.2469)


A neolignan isolated from Sinocalamus affinis.

   
   

methyl 2-[(1r,3s,4s,5r,7r,8s,10s,11r,12r,13r)-4,5,11-tris(acetyloxy)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-9,15-dioxo-2,14-dioxatetracyclo[8.6.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

methyl 2-[(1r,3s,4s,5r,7r,8s,10s,11r,12r,13r)-4,5,11-tris(acetyloxy)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-9,15-dioxo-2,14-dioxatetracyclo[8.6.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

C33H40O13 (644.2469)


   

methyl 2-[(1r,3r,4r,5s,7s,8r,10r,12s,13s)-4,5,10-tris(acetyloxy)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-9,15-dioxo-2,14-dioxatetracyclo[8.6.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

methyl 2-[(1r,3r,4r,5s,7s,8r,10r,12s,13s)-4,5,10-tris(acetyloxy)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-9,15-dioxo-2,14-dioxatetracyclo[8.6.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

C33H40O13 (644.2469)


   

(±)-Bbuddlenol D

NA

C33H40O13 (644.2469)


{"Ingredient_id": "HBIN017655","Ingredient_name": "(±)-Bbuddlenol D","Alias": "NA","Ingredient_formula": "C33H40O13","Ingredient_Smile": "COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)OC(CO)C(C5=CC(=C(C(=C5)OC)O)OC)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "34050","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-[(2r,3s,4r,5s,6r)-3,4-dihydroxy-6-({[(2s,4s,5s)-4-hydroxy-5-(methylamino)oxan-2-yl]oxy}methyl)-5-methoxyoxan-2-yl]-13-methyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaene-12,14-dione

3-[(2r,3s,4r,5s,6r)-3,4-dihydroxy-6-({[(2s,4s,5s)-4-hydroxy-5-(methylamino)oxan-2-yl]oxy}methyl)-5-methoxyoxan-2-yl]-13-methyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaene-12,14-dione

C34H36N4O9 (644.2482)


   

(1r,2s)-2-{4-[(1r,3as,4r,6as)-4-(4-hydroxy-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-1-(4-hydroxy-3,5-dimethoxyphenyl)propane-1,3-diol

(1r,2s)-2-{4-[(1r,3as,4r,6as)-4-(4-hydroxy-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-1-(4-hydroxy-3,5-dimethoxyphenyl)propane-1,3-diol

C33H40O13 (644.2469)


   

(1r,2s)-2-{4-[(1r,3ar,4r,6as)-4-(4-hydroxy-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-1-(4-hydroxy-3,5-dimethoxyphenyl)propane-1,3-diol

(1r,2s)-2-{4-[(1r,3ar,4r,6as)-4-(4-hydroxy-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-1-(4-hydroxy-3,5-dimethoxyphenyl)propane-1,3-diol

C33H40O13 (644.2469)


   

3-[3,4-dihydroxy-6-({[4-hydroxy-5-(methylamino)oxan-2-yl]oxy}methyl)-5-methoxyoxan-2-yl]-13-methyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaene-12,14-dione

3-[3,4-dihydroxy-6-({[4-hydroxy-5-(methylamino)oxan-2-yl]oxy}methyl)-5-methoxyoxan-2-yl]-13-methyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaene-12,14-dione

C34H36N4O9 (644.2482)


   

3-[(3r,4r,5s,6r)-3,4-dihydroxy-6-({[(2s,4s,5s)-4-hydroxy-5-(methylamino)oxan-2-yl]oxy}methyl)-5-methoxyoxan-2-yl]-13-methyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaene-12,14-dione

3-[(3r,4r,5s,6r)-3,4-dihydroxy-6-({[(2s,4s,5s)-4-hydroxy-5-(methylamino)oxan-2-yl]oxy}methyl)-5-methoxyoxan-2-yl]-13-methyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaene-12,14-dione

C34H36N4O9 (644.2482)


   

methyl 2-[4,5,11-tris(acetyloxy)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-9,15-dioxo-2,14-dioxatetracyclo[8.6.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

methyl 2-[4,5,11-tris(acetyloxy)-13-(furan-3-yl)-6,6,8,12-tetramethyl-17-methylidene-9,15-dioxo-2,14-dioxatetracyclo[8.6.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

C33H40O13 (644.2469)